Hyperlipidaemia and aortic valve disease

Degenerative aortic valve stenosis is a common disease in the elderly, and traditional risk factors for atherosclerotic disease including hyperlipidaemia have been associated with the condition in several studies. This review addresses the role of the various risk factors and the potential for inter...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in lipidology 2004-08, Vol.15 (4), p.447-451
Hauptverfasser: Rossebø, Anne Bjørhovde, Pedersen, Terje R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 451
container_issue 4
container_start_page 447
container_title Current opinion in lipidology
container_volume 15
creator Rossebø, Anne Bjørhovde
Pedersen, Terje R
description Degenerative aortic valve stenosis is a common disease in the elderly, and traditional risk factors for atherosclerotic disease including hyperlipidaemia have been associated with the condition in several studies. This review addresses the role of the various risk factors and the potential for intervention. The association of lipid abnormalities such as high lipoprotein(a) levels and the presence of the apolipoprotein E4 allele with aortic stenosis, as well as the presence of several inflammatory markers both in plasma and in surgically excised valves, suggest that the stenotic process is driven by many of the same factors behind atherosclerosis. The aortic valves of animals fed a cholesterol-rich diet exhibit many characteristics in common with the early stages of aortic stenosis. This opens up the potential of retarding the process through intervention strategies. Hyperlipidaemia is associated with degenerative aortic valve stenosis, and the disease resembles the inflammatory process of atherosclerosis. Randomized controlled clinical trials will be needed to demonstrate the role of lipid intervention in patients with this condition.
doi_str_mv 10.1097/01.mol.0000137229.00020.fe
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66687644</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66687644</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-2e164b94ce501b84a81156b2a451de26c96b218598247cb663957c7a59f11ca73</originalsourceid><addsrcrecordid>eNpFkE9Lw0AQxfeg2Fr9ChI8iJfEnc3-yXqTolYoeNHzstlMYCVp4m5T6Ld3awudy8zAe_OGHyH3QAugWj1RKPqhK2gqKBVj-jAyWrR4QeZUC5VrqdiMXMf4kyRMU3VFZiAYLxlUc_K42o8YOj_6xmLvbWY3TWaHsPUu29luh1njI9qIN-SytV3E21NfkO-316_lKl9_vn8sX9a5K0Fsc4Ygea25Q0GhrritAISsmeUCGmTS6bRAJXTFuHK1lGX60SkrdAvgrCoX5OF4dwzD74Rxa3ofHXad3eAwRSOlrJTkPAmfj0IXhhgDtmYMvrdhb4CaAxtDwSQ25szG_LMxLSbz3SllqntsztYTmPIPHV9hhQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66687644</pqid></control><display><type>article</type><title>Hyperlipidaemia and aortic valve disease</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Rossebø, Anne Bjørhovde ; Pedersen, Terje R</creator><creatorcontrib>Rossebø, Anne Bjørhovde ; Pedersen, Terje R</creatorcontrib><description>Degenerative aortic valve stenosis is a common disease in the elderly, and traditional risk factors for atherosclerotic disease including hyperlipidaemia have been associated with the condition in several studies. This review addresses the role of the various risk factors and the potential for intervention. The association of lipid abnormalities such as high lipoprotein(a) levels and the presence of the apolipoprotein E4 allele with aortic stenosis, as well as the presence of several inflammatory markers both in plasma and in surgically excised valves, suggest that the stenotic process is driven by many of the same factors behind atherosclerosis. The aortic valves of animals fed a cholesterol-rich diet exhibit many characteristics in common with the early stages of aortic stenosis. This opens up the potential of retarding the process through intervention strategies. Hyperlipidaemia is associated with degenerative aortic valve stenosis, and the disease resembles the inflammatory process of atherosclerosis. Randomized controlled clinical trials will be needed to demonstrate the role of lipid intervention in patients with this condition.</description><identifier>ISSN: 0957-9672</identifier><identifier>DOI: 10.1097/01.mol.0000137229.00020.fe</identifier><identifier>PMID: 15243218</identifier><language>eng</language><publisher>England</publisher><subject>Aortic Valve - pathology ; Aortic Valve Stenosis - pathology ; Aortic Valve Stenosis - prevention &amp; control ; Apolipoproteins - metabolism ; Arteriosclerosis - pathology ; Arteriosclerosis - prevention &amp; control ; Humans ; Hyperlipidemias - complications ; Hyperlipidemias - pathology ; Hyperlipidemias - prevention &amp; control ; Inflammation ; Lipid Metabolism ; Lipoproteins, LDL - metabolism ; Risk Factors</subject><ispartof>Current opinion in lipidology, 2004-08, Vol.15 (4), p.447-451</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-2e164b94ce501b84a81156b2a451de26c96b218598247cb663957c7a59f11ca73</citedby><cites>FETCH-LOGICAL-c315t-2e164b94ce501b84a81156b2a451de26c96b218598247cb663957c7a59f11ca73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15243218$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rossebø, Anne Bjørhovde</creatorcontrib><creatorcontrib>Pedersen, Terje R</creatorcontrib><title>Hyperlipidaemia and aortic valve disease</title><title>Current opinion in lipidology</title><addtitle>Curr Opin Lipidol</addtitle><description>Degenerative aortic valve stenosis is a common disease in the elderly, and traditional risk factors for atherosclerotic disease including hyperlipidaemia have been associated with the condition in several studies. This review addresses the role of the various risk factors and the potential for intervention. The association of lipid abnormalities such as high lipoprotein(a) levels and the presence of the apolipoprotein E4 allele with aortic stenosis, as well as the presence of several inflammatory markers both in plasma and in surgically excised valves, suggest that the stenotic process is driven by many of the same factors behind atherosclerosis. The aortic valves of animals fed a cholesterol-rich diet exhibit many characteristics in common with the early stages of aortic stenosis. This opens up the potential of retarding the process through intervention strategies. Hyperlipidaemia is associated with degenerative aortic valve stenosis, and the disease resembles the inflammatory process of atherosclerosis. Randomized controlled clinical trials will be needed to demonstrate the role of lipid intervention in patients with this condition.</description><subject>Aortic Valve - pathology</subject><subject>Aortic Valve Stenosis - pathology</subject><subject>Aortic Valve Stenosis - prevention &amp; control</subject><subject>Apolipoproteins - metabolism</subject><subject>Arteriosclerosis - pathology</subject><subject>Arteriosclerosis - prevention &amp; control</subject><subject>Humans</subject><subject>Hyperlipidemias - complications</subject><subject>Hyperlipidemias - pathology</subject><subject>Hyperlipidemias - prevention &amp; control</subject><subject>Inflammation</subject><subject>Lipid Metabolism</subject><subject>Lipoproteins, LDL - metabolism</subject><subject>Risk Factors</subject><issn>0957-9672</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE9Lw0AQxfeg2Fr9ChI8iJfEnc3-yXqTolYoeNHzstlMYCVp4m5T6Ld3awudy8zAe_OGHyH3QAugWj1RKPqhK2gqKBVj-jAyWrR4QeZUC5VrqdiMXMf4kyRMU3VFZiAYLxlUc_K42o8YOj_6xmLvbWY3TWaHsPUu29luh1njI9qIN-SytV3E21NfkO-316_lKl9_vn8sX9a5K0Fsc4Ygea25Q0GhrritAISsmeUCGmTS6bRAJXTFuHK1lGX60SkrdAvgrCoX5OF4dwzD74Rxa3ofHXad3eAwRSOlrJTkPAmfj0IXhhgDtmYMvrdhb4CaAxtDwSQ25szG_LMxLSbz3SllqntsztYTmPIPHV9hhQ</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Rossebø, Anne Bjørhovde</creator><creator>Pedersen, Terje R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040801</creationdate><title>Hyperlipidaemia and aortic valve disease</title><author>Rossebø, Anne Bjørhovde ; Pedersen, Terje R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-2e164b94ce501b84a81156b2a451de26c96b218598247cb663957c7a59f11ca73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aortic Valve - pathology</topic><topic>Aortic Valve Stenosis - pathology</topic><topic>Aortic Valve Stenosis - prevention &amp; control</topic><topic>Apolipoproteins - metabolism</topic><topic>Arteriosclerosis - pathology</topic><topic>Arteriosclerosis - prevention &amp; control</topic><topic>Humans</topic><topic>Hyperlipidemias - complications</topic><topic>Hyperlipidemias - pathology</topic><topic>Hyperlipidemias - prevention &amp; control</topic><topic>Inflammation</topic><topic>Lipid Metabolism</topic><topic>Lipoproteins, LDL - metabolism</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rossebø, Anne Bjørhovde</creatorcontrib><creatorcontrib>Pedersen, Terje R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in lipidology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rossebø, Anne Bjørhovde</au><au>Pedersen, Terje R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperlipidaemia and aortic valve disease</atitle><jtitle>Current opinion in lipidology</jtitle><addtitle>Curr Opin Lipidol</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>15</volume><issue>4</issue><spage>447</spage><epage>451</epage><pages>447-451</pages><issn>0957-9672</issn><abstract>Degenerative aortic valve stenosis is a common disease in the elderly, and traditional risk factors for atherosclerotic disease including hyperlipidaemia have been associated with the condition in several studies. This review addresses the role of the various risk factors and the potential for intervention. The association of lipid abnormalities such as high lipoprotein(a) levels and the presence of the apolipoprotein E4 allele with aortic stenosis, as well as the presence of several inflammatory markers both in plasma and in surgically excised valves, suggest that the stenotic process is driven by many of the same factors behind atherosclerosis. The aortic valves of animals fed a cholesterol-rich diet exhibit many characteristics in common with the early stages of aortic stenosis. This opens up the potential of retarding the process through intervention strategies. Hyperlipidaemia is associated with degenerative aortic valve stenosis, and the disease resembles the inflammatory process of atherosclerosis. Randomized controlled clinical trials will be needed to demonstrate the role of lipid intervention in patients with this condition.</abstract><cop>England</cop><pmid>15243218</pmid><doi>10.1097/01.mol.0000137229.00020.fe</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0957-9672
ispartof Current opinion in lipidology, 2004-08, Vol.15 (4), p.447-451
issn 0957-9672
language eng
recordid cdi_proquest_miscellaneous_66687644
source MEDLINE; Journals@Ovid Complete
subjects Aortic Valve - pathology
Aortic Valve Stenosis - pathology
Aortic Valve Stenosis - prevention & control
Apolipoproteins - metabolism
Arteriosclerosis - pathology
Arteriosclerosis - prevention & control
Humans
Hyperlipidemias - complications
Hyperlipidemias - pathology
Hyperlipidemias - prevention & control
Inflammation
Lipid Metabolism
Lipoproteins, LDL - metabolism
Risk Factors
title Hyperlipidaemia and aortic valve disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A51%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperlipidaemia%20and%20aortic%20valve%20disease&rft.jtitle=Current%20opinion%20in%20lipidology&rft.au=Rosseb%C3%B8,%20Anne%20Bj%C3%B8rhovde&rft.date=2004-08-01&rft.volume=15&rft.issue=4&rft.spage=447&rft.epage=451&rft.pages=447-451&rft.issn=0957-9672&rft_id=info:doi/10.1097/01.mol.0000137229.00020.fe&rft_dat=%3Cproquest_cross%3E66687644%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66687644&rft_id=info:pmid/15243218&rfr_iscdi=true